Şerife Bektaş1, Mine Çavuş2, Sema Turan1. 1. Department of Intensive Care Unit, Ankara State Hospital, Ankara, Turkey. 2. Department of Intensive Care Unit, Kayseri State Hospital, Kayseri, Turkey.
Abstract
BACKGROUND: We aimed to investigate the efficacy and safety of percutaneous dilatational tracheostomy procedure following cardiac surgery in patients receiving extracorporeal membrane oxygenation and/or left ventricular assist device. METHODS: A total of 42 patients (10 males, 32 females; mean age 51±14.6 years; range, 18 to 77 years) who underwent percutaneous dilatational tracheostomy procedure under extracorporeal membrane oxygenation and/or left ventricular assist device support between January 2017 and January 2019 were retrospectively analyzed. Laboratory data, Simplified Acute Physiology Score-II and Sequential Organ Failure Assessment scores, and major and minor complications were recorded. The 30-day and one-year follow-up outcomes of the patients were reviewed. RESULTS: Of 42 patients, 17 (42.5%), 14 (33.3%), and 11 (26.2%) received left ventricular assist device, extracorporeal membrane oxygenation, and extracorporeal membrane oxygenation + left ventricular assist device, respectively. During percutaneous dilatational tracheostomy, the laboratory values of the patients were as follows: international normalized ratio, 2.3±0.9; partial thromboplastin time, 59.4±19.5 sec; platelet count, 139.2±65.8×109/L, hemoglobin, 8.8±1.0 g/dL, and creatinine, 1.6±1.0 mg/dL. No peri-procedural mortality, major complication, or bleeding was observed. We observed minor complications including localized stomal ooze in four patients (8.3%) and local stomal infection in three patients (6.2%). CONCLUSION: Our study results suggest that percutaneous dilatational tracheostomy is an effective and safe technique in this patient population.
BACKGROUND: We aimed to investigate the efficacy and safety of percutaneous dilatational tracheostomy procedure following cardiac surgery in patients receiving extracorporeal membrane oxygenation and/or left ventricular assist device. METHODS: A total of 42 patients (10 males, 32 females; mean age 51±14.6 years; range, 18 to 77 years) who underwent percutaneous dilatational tracheostomy procedure under extracorporeal membrane oxygenation and/or left ventricular assist device support between January 2017 and January 2019 were retrospectively analyzed. Laboratory data, Simplified Acute Physiology Score-II and Sequential Organ Failure Assessment scores, and major and minor complications were recorded. The 30-day and one-year follow-up outcomes of the patients were reviewed. RESULTS: Of 42 patients, 17 (42.5%), 14 (33.3%), and 11 (26.2%) received left ventricular assist device, extracorporeal membrane oxygenation, and extracorporeal membrane oxygenation + left ventricular assist device, respectively. During percutaneous dilatational tracheostomy, the laboratory values of the patients were as follows: international normalized ratio, 2.3±0.9; partial thromboplastin time, 59.4±19.5 sec; platelet count, 139.2±65.8×109/L, hemoglobin, 8.8±1.0 g/dL, and creatinine, 1.6±1.0 mg/dL. No peri-procedural mortality, major complication, or bleeding was observed. We observed minor complications including localized stomal ooze in four patients (8.3%) and local stomal infection in three patients (6.2%). CONCLUSION: Our study results suggest that percutaneous dilatational tracheostomy is an effective and safe technique in this patient population.
Authors: Andreas Schaefer; Yvonne Schneeberger; Daniel Reichart; Alexander M Bernhardt; Mathias Kubik; Markus J Barten; Florian M Wagner; Stefan Kluge; Hermann Reichenspurner; Sebastian A Philipp Journal: ASAIO J Date: 2016 Nov/Dec Impact factor: 2.872
Authors: Stephan Braune; Susanne Kienast; Johannes Hadem; Olaf Wiesner; Dominic Wichmann; Axel Nierhaus; Marcel Simon; Tobias Welte; Stefan Kluge Journal: Intensive Care Med Date: 2013-07-27 Impact factor: 17.440
Authors: Onat Bermede; Mehmet Cahit Sarıcaoğlu; Volkan Baytaş; Ali İhsan Hasde; Mustafa Bahadır İnan; Ahmet Rüçhan Akar Journal: Turk Gogus Kalp Damar Cerrahisi Derg Date: 2021-10-20 Impact factor: 0.332